Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

3.600 +0.230 (+6.82%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

August 14, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

July 23, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

July 15, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

June 24, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Announces Participation in 2025 BIO International Convention

June 16, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders

June 10, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds

June 03, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

May 28, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

May 20, 2025

From Enveric Biosciences

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 16, 2025

Via Benzinga

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

May 14, 2025

From Enveric Biosciences

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 21, 2025

Via Benzinga

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

March 31, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Participating in BIO-Europe Spring®

March 17, 2025

From Enveric Biosciences, Inc.

Via Business Wire

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

March 06, 2025

From Enveric Biosciences

Via Business Wire

Keep an eye on the top gainers and losers in Friday's session. ↗

February 28, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

These stocks have an unusual volume in today's session ↗

February 28, 2025

Volume analysis on 2025-02-28: stocks with an unusual volume in today's session.

Via Chartmill

Enveric Biosciences CEO Issues Letter to Shareholders

February 27, 2025

From Enveric Biosciences

Via Business Wire

These stocks are moving in today's after hours session ↗

February 26, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

What's going on in today's session ↗

February 26, 2025

Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Check out the stocks that are attracting the most attention and driving market activity. ↗

February 26, 2025

Let's dive into the action on the US markets on Wednesday. Here are the most active stocks that are driving the market today.

Via Chartmill

Dow Dips Over 100 Points; TJX Earnings Top Views ↗

February 26, 2025

Via Benzinga

Topics Stocks

Here are the top movers in Wednesday's session. ↗

February 26, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Nasdaq Surges 150 Points; Lowe's Posts Upbeat Earnings ↗

February 26, 2025

Via Benzinga

Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum

February 26, 2025

Via AB Newswire

Topics Artificial Intelligence Derivatives Intellectual Property

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

February 26, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

These stocks are moving in today's pre-market session ↗

February 26, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert ↗

February 26, 2025

U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.

Via Benzinga

Topics Stocks

Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

February 26, 2025

Via Benzinga

Which stocks are moving after the closing bell on Tuesday? ↗

February 25, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.